Company intelligence / Profile preview

Dalim

Seoul, Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

Dalim Tissen markets CE-approved collagen medical devices for surgical, dental, wound care, and cosmeceutical use. They emphasize high purity, safety, and clinical collaborations with leading academic medical centers[1].

Therapeutic areas: HematologyDermatologyOther
Modalities: BiologicDeviceNatural polymer
Industry: Therapeutic Medical Devices

Partnerships

Collaboration with Asan Institute for Life Science/Asan Medical Center (leading Korean academic hospital)

Beyond the preview

Go deeper on Dalim.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dalim.

Explore the full profile